IBDEI0LF ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9993,1,4,0)
 ;;=4^H40.243
 ;;^UTILITY(U,$J,358.3,9993,2)
 ;;=^5005845
 ;;^UTILITY(U,$J,358.3,9994,0)
 ;;=H40.043^^44^496^121
 ;;^UTILITY(U,$J,358.3,9994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9994,1,3,0)
 ;;=3^Steroid Responder,Bilateral
 ;;^UTILITY(U,$J,358.3,9994,1,4,0)
 ;;=4^H40.043
 ;;^UTILITY(U,$J,358.3,9994,2)
 ;;=^5005738
 ;;^UTILITY(U,$J,358.3,9995,0)
 ;;=B02.39^^44^497^10
 ;;^UTILITY(U,$J,358.3,9995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9995,1,3,0)
 ;;=3^Herpes Zoster Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,9995,1,4,0)
 ;;=4^B02.39
 ;;^UTILITY(U,$J,358.3,9995,2)
 ;;=^5000498
 ;;^UTILITY(U,$J,358.3,9996,0)
 ;;=B00.59^^44^497^9
 ;;^UTILITY(U,$J,358.3,9996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9996,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,9996,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,9996,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,9997,0)
 ;;=B25.9^^44^497^8
 ;;^UTILITY(U,$J,358.3,9997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9997,1,3,0)
 ;;=3^Cytomegaloviral Disease,Unspec
 ;;^UTILITY(U,$J,358.3,9997,1,4,0)
 ;;=4^B25.9
 ;;^UTILITY(U,$J,358.3,9997,2)
 ;;=^5000560
 ;;^UTILITY(U,$J,358.3,9998,0)
 ;;=H32.^^44^497^6
 ;;^UTILITY(U,$J,358.3,9998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9998,1,3,0)
 ;;=3^Chorioretinal Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,9998,1,4,0)
 ;;=4^H32.
 ;;^UTILITY(U,$J,358.3,9998,2)
 ;;=^5005489
 ;;^UTILITY(U,$J,358.3,9999,0)
 ;;=B39.9^^44^497^11
 ;;^UTILITY(U,$J,358.3,9999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9999,1,3,0)
 ;;=3^Histoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,9999,1,4,0)
 ;;=4^B39.9
 ;;^UTILITY(U,$J,358.3,9999,2)
 ;;=^5000638
 ;;^UTILITY(U,$J,358.3,10000,0)
 ;;=B83.0^^44^497^25
 ;;^UTILITY(U,$J,358.3,10000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10000,1,3,0)
 ;;=3^Visceral Larva Migrans
 ;;^UTILITY(U,$J,358.3,10000,1,4,0)
 ;;=4^B83.0
 ;;^UTILITY(U,$J,358.3,10000,2)
 ;;=^5000799
 ;;^UTILITY(U,$J,358.3,10001,0)
 ;;=B58.01^^44^497^24
 ;;^UTILITY(U,$J,358.3,10001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10001,1,3,0)
 ;;=3^Toxoplasma Chorioretinitis
 ;;^UTILITY(U,$J,358.3,10001,1,4,0)
 ;;=4^B58.01
 ;;^UTILITY(U,$J,358.3,10001,2)
 ;;=^5000724
 ;;^UTILITY(U,$J,358.3,10002,0)
 ;;=H44.001^^44^497^22
 ;;^UTILITY(U,$J,358.3,10002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10002,1,3,0)
 ;;=3^Purulent Endophthalmitis,Right Eye,Unspec
 ;;^UTILITY(U,$J,358.3,10002,1,4,0)
 ;;=4^H44.001
 ;;^UTILITY(U,$J,358.3,10002,2)
 ;;=^5005963
 ;;^UTILITY(U,$J,358.3,10003,0)
 ;;=H44.002^^44^497^21
 ;;^UTILITY(U,$J,358.3,10003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10003,1,3,0)
 ;;=3^Purulent Endophthalmitis,Left Eye,Unspec
 ;;^UTILITY(U,$J,358.3,10003,1,4,0)
 ;;=4^H44.002
 ;;^UTILITY(U,$J,358.3,10003,2)
 ;;=^5005964
 ;;^UTILITY(U,$J,358.3,10004,0)
 ;;=H44.003^^44^497^20
 ;;^UTILITY(U,$J,358.3,10004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10004,1,3,0)
 ;;=3^Purulent Endophthalmitis,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,10004,1,4,0)
 ;;=4^H44.003
 ;;^UTILITY(U,$J,358.3,10004,2)
 ;;=^5005965
 ;;^UTILITY(U,$J,358.3,10005,0)
 ;;=H16.061^^44^497^19
 ;;^UTILITY(U,$J,358.3,10005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10005,1,3,0)
 ;;=3^Mycotic Corneal Ulcer,Right Eye
 ;;^UTILITY(U,$J,358.3,10005,1,4,0)
 ;;=4^H16.061
 ;;^UTILITY(U,$J,358.3,10005,2)
 ;;=^5004890
 ;;^UTILITY(U,$J,358.3,10006,0)
 ;;=H16.062^^44^497^18
 ;;^UTILITY(U,$J,358.3,10006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10006,1,3,0)
 ;;=3^Mycotic Corneal Ulcer,Left Eye
 ;;^UTILITY(U,$J,358.3,10006,1,4,0)
 ;;=4^H16.062
